数智信息推进药学改革,药事服务提高医疗质量  

Digital and Intelligence Promoting Pharmaceutical Reform,Pharmaceutical Care Improving Medical Quality

作　　者：董曦浩[1] 姜赛平[1] 卢晓阳[1] 吴佳莹[1] 韩舒盈[1] DONG Xihao;JIANG Saiping;LU Xiaoyang;WU Jiaying;HAN Shuying(The First Affiliated Hospital of Zhejiang University Medical College,Hangzhou 310000,China)

机构地区：[1]浙江大学医学院附属第一医院,杭州310000

出　　处：《中国现代应用药学》2022年第21期2717-2720,共4页Chinese Journal of Modern Applied Pharmacy

摘　　要：数智化改革是药学事业中的热点话题。但数智化改革存在现行监管上的政策难点和运用模式上的思想盲区。为进一步推进药学事业数智化改革进程,提升药事服务质量。本期推出“数智药学——智慧药事管理”专栏,从“药品智慧监管”和“数智药房建设与管理、数字技术在临床试验中的应用”两方面深入探讨,以期在政策监管、数智化平台构建运用、药事服务质量提升等内容上展现国内研究水平和分享成功经验,为我国药学事业的转型提供新思路、新助力。Reform of digital and intelligence is a hot topic in pharmacy.However,the reform of digital intelligence has policy difficulties in the current supervision and blind spots in the application model.To further promote the digital and intellectual reform process of pharmacy,and improve the quality of pharmaceutical services.This issue introduces the column of “Digital and Intelligence Pharmacy:Intelligent Pharmacy Management”,deeply discuss from two aspects of “intelligent supervision of drugs” and “construction and management of digital intelligence pharmacy,application of digital technology in clinical trials”,is supposed to show our domestic research level and share successful experience in policy supervision,construction and application of digital intelligence platform,improvement of pharmaceutical service quality,provide new ideas and support for the transformation of China’s pharmaceutical industry.

关 键 词：数智化 智慧监管 药事管理 药事服务 

分 类 号：R952[医药卫生—药学]